ADXN Addex Therapeutics Ltd

NASDAQ
$3.65

Addex Therapeutics Ltd (ADXN) is expected to report earnings on September 28, 2026, before the market open.

Addex Therapeutics Reported Earnings
Thursday, June 25, 2026 · 1:00 AM ET
Earnings Date
Sep 28
Monday · 1:00 AM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Addex Therapeutics Ltd

Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators for neurological disorders.

Sector

Healthcare

Industry

Biotechnology